| mRNA |
PIK-93 |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0075 |
0.9 |
| mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.9 |
| mRNA |
Salubrinal |
GDSC1000 |
pan-cancer |
AAC |
0.011 |
0.9 |
| mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.0072 |
0.9 |
| mRNA |
staurosporine |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.9 |
| mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
0.0092 |
0.9 |
| mRNA |
ML334 diastereomer |
CTRPv2 |
pan-cancer |
AAC |
-0.009 |
0.9 |
| mRNA |
SB 505124 |
GDSC1000 |
pan-cancer |
AAC |
0.0069 |
0.9 |
| mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.9 |